Veracyte's GAAP loss for 9M 2021 was $65.035 million, up 2.4 times from $26.865 million in the previous year. Revenue increased 83.5% to $152.178 million from $82.947 million a year earlier.
Veracyte's GAAP loss for 9M 2021 was $65.035 million, up 2.4 times from $26.865 million in the previous year. Revenue increased 83.5% to $152.178 million from $82.947 million a year earlier. 
investor.veracyte.com
English (US) 